Ensysce Biosciences Stock Technical Analysis
| ENSC Stock | USD 0.71 0.02 2.74% |
As of the 2nd of February, Ensysce Biosciences shows the Standard Deviation of 5.01, mean deviation of 3.72, and Variance of 25.08. Ensysce Biosciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Ensysce Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Ensysce, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EnsysceEnsysce Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Ensysce Biosciences Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 19.23 | Buy | 1 | Odds |
Most Ensysce analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ensysce stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ensysce Biosciences, talking to its executives and customers, or listening to Ensysce conference calls.
Will Biotechnology sector continue expanding? Could Ensysce diversify its offerings? Factors like these will boost the valuation of Ensysce Biosciences. Projected growth potential of Ensysce fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ensysce Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (6.32) | Revenue Per Share | Quarterly Revenue Growth (0.86) | Return On Assets | Return On Equity |
Investors evaluate Ensysce Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ensysce Biosciences' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Ensysce Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Ensysce Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ensysce Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Ensysce Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.
Ensysce Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ensysce Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ensysce Biosciences.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Ensysce Biosciences on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Ensysce Biosciences or generate 0.0% return on investment in Ensysce Biosciences over 90 days. Ensysce Biosciences is related to or competes with Soligenix, Oragenics, Kala Pharmaceuticals, Xenetic Biosciences, AIM ImmunoTech, Vyne Therapeutics, and Kazia Therapeutics. Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for... More
Ensysce Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ensysce Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ensysce Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.31) | |||
| Maximum Drawdown | 23.86 | |||
| Value At Risk | (10.78) | |||
| Potential Upside | 5.94 |
Ensysce Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ensysce Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ensysce Biosciences' standard deviation. In reality, there are many statistical measures that can use Ensysce Biosciences historical prices to predict the future Ensysce Biosciences' volatility.| Risk Adjusted Performance | (0.21) | |||
| Jensen Alpha | (1.56) | |||
| Total Risk Alpha | (1.83) | |||
| Treynor Ratio | (1.79) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ensysce Biosciences February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.21) | |||
| Market Risk Adjusted Performance | (1.78) | |||
| Mean Deviation | 3.72 | |||
| Coefficient Of Variation | (331.33) | |||
| Standard Deviation | 5.01 | |||
| Variance | 25.08 | |||
| Information Ratio | (0.31) | |||
| Jensen Alpha | (1.56) | |||
| Total Risk Alpha | (1.83) | |||
| Treynor Ratio | (1.79) | |||
| Maximum Drawdown | 23.86 | |||
| Value At Risk | (10.78) | |||
| Potential Upside | 5.94 | |||
| Skewness | 0.148 | |||
| Kurtosis | 0.8491 |
Ensysce Biosciences Backtested Returns
Ensysce Biosciences secures Sharpe Ratio (or Efficiency) of -0.31, which denotes the company had a -0.31 % return per unit of risk over the last 3 months. Ensysce Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Ensysce Biosciences' Standard Deviation of 5.01, mean deviation of 3.72, and Variance of 25.08 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.85, which means possible diversification benefits within a given portfolio. Ensysce Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Ensysce Biosciences is expected to follow. At this point, Ensysce Biosciences has a negative expected return of -1.61%. Please make sure to confirm Ensysce Biosciences' skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Ensysce Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.77 |
Good predictability
Ensysce Biosciences has good predictability. Overlapping area represents the amount of predictability between Ensysce Biosciences time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ensysce Biosciences price movement. The serial correlation of 0.77 indicates that around 77.0% of current Ensysce Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.77 | |
| Spearman Rank Test | 0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Ensysce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Ensysce Biosciences Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Ensysce Biosciences across different markets.
About Ensysce Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Ensysce Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Ensysce Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Ensysce Biosciences price pattern first instead of the macroeconomic environment surrounding Ensysce Biosciences. By analyzing Ensysce Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Ensysce Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Ensysce Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 18.35 | 16.31 | Price To Sales Ratio | 3.14 | 2.98 |
Ensysce Biosciences February 2, 2026 Technical Indicators
Most technical analysis of Ensysce help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ensysce from various momentum indicators to cycle indicators. When you analyze Ensysce charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.21) | |||
| Market Risk Adjusted Performance | (1.78) | |||
| Mean Deviation | 3.72 | |||
| Coefficient Of Variation | (331.33) | |||
| Standard Deviation | 5.01 | |||
| Variance | 25.08 | |||
| Information Ratio | (0.31) | |||
| Jensen Alpha | (1.56) | |||
| Total Risk Alpha | (1.83) | |||
| Treynor Ratio | (1.79) | |||
| Maximum Drawdown | 23.86 | |||
| Value At Risk | (10.78) | |||
| Potential Upside | 5.94 | |||
| Skewness | 0.148 | |||
| Kurtosis | 0.8491 |
Ensysce Biosciences February 2, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Ensysce stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 5,027 | ||
| Daily Balance Of Power | (0.67) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 0.71 | ||
| Day Typical Price | 0.71 | ||
| Price Action Indicator | (0.01) |
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |